Found 22 results

2009
Heerspink HJL, Ninomiya T, Zoungas S, de Zeeuw D, Grobbee DE, Jardine M, Gallagher M, Roberts MA, Cass A, Neal B et al..  2009.  Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials . Lancet. 373:1009-1015.[IF28.638].
Hu J, Jiang X, Li N, Yu X, Perkovic V, Chen B, Zhao L, Neal B, Wu Y.  2009.  Effects of salt substitute on pulse wave analysis among individuals at high cardiovascular risk in rural China: a randomized controlled trial. Hypertensenion Research. 32:282-8[IF2.9].
ADVANCE Collaborative Group, Writing Committee, Ninomiya T, Perkovic V, de Galan B, Zoungas S, Pillai A, Jardine M, Patel A, Cass A et al..  2009.  Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol. 20:1813-21.[IF7.111]..
Perkovic V, Heerspink HL, Ninomiya T, Cass A, Neal B.  2009.  Blood pressure in dialysis patients-look before we leap. Reply. Lancet. 373:1945-46.[IF28.409]..
Asia Pacific Cohort Studies Collaboration, Writing Committee, O’Seaghdha CM, Perkovic V, Lam TH, McGinn S, Barzi F , Gu DF, Cass A, Suh I et al..  2009.  Blood pressure is a major risk factor for renal death. An analysis of 560 352 participants from the Asia-Pacific region. . Hypertension . 54:509-15.[IF7.368]..
Perkovic V, Ninomiya T, Macmahon S, Chalmers J.  2009.  Chapter 9: Renal and microalbuminuria data from ADVANCE. Role of Macro and Microcirculation in Target Organ Damage in Diabetes and Hypertension.
Huxley R , Lee C, Barzi F , Timmermeister L, Czernichow S , Perkovic V, Grobbee D, Batty D, Woodward M.  2009.  Coffee, Decaffeinated Coffee, and Tea Consumption in Relation to Incident Type-II Diabetes Mellitus: A Systematic Review with Meta-analysis. Archives of Internal Medicine. 169:2053-63.[IF9.110].
Gallagher M, Jardine M, Perkovic V, Cass A, McDonald S, Petrie J, Eris J.  2009.  Cyclosporine withdrawal improves long term graft survival in renal transplantation. Transplantation. 87:1877-83.[IF3.641]..
Navaneethan S, Perkovic V, Johnson D, Nigwekar S, Craig J, Strippoli G.  2009.  HMG CoA reductase inhibitors (statins) for dialysis patients. Cochrane Database of Systematic Reviews. 3:CD004289. [IF 4.654].
Huxley RR, Clifton P, Perkovic V, Woodward M, Neal B.  2009.  How many Australian deaths from heart disease and stroke could be avoided by a small reduction in population cholesterol levels? Nutrition Dietetics. 66:158-63.[IF0.000].
Jun M, Zoungas S, Perkovic V, Webster A.  2009.  How to read a report of a randomised controlled trial. Nephrology. In press. [IF 1.215]
Nigwekar SU, Cass A, Gallagher M, Jardine MJ, Kang A, Kulshrestha S, Navaneethan SD, Perkovic V, Strippoli G, Zoungas S.  2009.  Interventions for lowering plasma homocysteine levels in dialysis patients [Protocol] . Cochrane Database of Systematic Reviews. 2:CD004683. [IF 4.654].
White S, Perkovic V, Cass A, Chang C, Poulter N, Spector T, Haysom L, Craig J, Al Salmi I, Chadban S et al..  2009.  Is low birth weight an antecedent of chronic kidney disease in later life? A systematic review of observational studies American Journal of Kidney Diseases . :[Epubaheadofprint].[IF3.981].
Ninomiya T, Perkovic V, Verdon C, Barzi F , Cass A, Gallagher M, Jardine M, Anderson C, Chalmers J, Craig JC et al..  2009.  Proteinuria and stroke: a meta-analysis of cohort studies. American Journal of Kidney Diseases. 5:417-25.[IF3.981]..
Heerspink HJL, Perkovic V, de Zeeuw D.  2009.  Renal and Cardiovascular effects of Direct Renin Inhibition. Journal of Hypertension. In press. [IF 5.138].
Joshi R , de Galan BE, Chalmers J, Perkovic V, Patel A.  2009.  Routine blood pressure lowering and intensive glucose control in patients with type 2 diabetes: results from the ADVANCE trial. Expert Reviews in Endocrinology & Metabolism. 4:111-18.[IF0].
ADVANCE Collaborative Group, de Galan BE, Perkovic V, Ninomiya T, Pillai A, Patel A, Cass A, Neal B, Poulter N, Harrap S et al..  2009.  Routine blood pressure lowering and kidney disease in type 2 diabetes. J Am Soc Nephrol. 20:883-92.[IF7.111].
Zoungas S, Ninomiya T, Cass A, Jardine M, Gallagher M, Huxley R , Patel A, Perkovic V.  2009.  Sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy: a systematic review. Annals of Internal Medicine. 151:631-8.[IF17.457].
2008
Cooper B, Gallery E, McLennan J, Ross-Styles M, Waugh D, McGinn C, Pollock C, Perkovic V, Gyory A.  2008.  The renal characteristics of patients with a history of lithium exposure as determined by formal renal function testing. Proceedings of the 44th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology. <i>Nephrology</i>. 2008;13(Suppl 3):A145. [IF 1.241]
Perkovic V, de Galan B, Chalmers J, Ninomiya T, Patel A, Cass A, Cooper M, Neal B, Macmahon S.  2008.  Renoprotection with perindopril-indapamide below current recommended blood pressure targets in patients with type 2 diabetes mellitus: results of the ADVANCE trial. Proceedings of the 44th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology. <i>Nephrology</i>. 2008;13(Suppl 3):A121. [IF 1.241]
Gallagher M, Webster A, Jardine M, Perkovic V, Cass A, Eris J.  2008.  Twenty year cancer outcomes of a randomized trial of immunosuppression in kidney transplant recipients: results of the Australian multicentre trial of cyclosporine withdrawal. Proceedings of the 44th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology. <i>Nephrology</i>. 2008;13(Suppl 3):A119. [IF 1.241]
2007
Gallagher M, Webster A, Jardine M, Perkovic V, Cass A, Eris J.  2007.  Twenty year cancer outcomes of a randomised trial of immunosuppression in kidney recipients: results of the Australian multi-centre trial of cyclosporine withdrawal. Proceedings of the Transplantation Society Joint Conference. <i>Transplantation</i>. 2008;86(Suppl 2):102. [IF 3.641]

Latest news

Recently added pages

Our focus

George Institute sites